Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD)

Molecules. 2020 Sep 27;25(19):4440. doi: 10.3390/molecules25194440.

Abstract

In this study, we critically review the literature concerning the relation of Mg, Fe, Zn, Cu and Se and attention-deficit/hyperactivity disorder (ADHD). Elemental status is estimated using peripheral blood parameters, hair, urine, daily intake and response to supplementation. The observed associations between concentration levels of the elements Mg, Fe, Zn, Cu and Se and ADHD symptoms are contradictory. This is partly due to the heterogeneity and complexity of the disorder. As a trend, lower ferritin and zinc levels can be observed. However, this correlation is not causative, as illustrated by placebo-controlled trials reporting conflicting evidence on the efficacy of supplementation. Well-defined studies on changes in concentration levels of the elements in relation to ADHD symptoms before and after treatment with therapeutics it will be possible to shed more light on the significance of these elements in this behavioral disorder. The discussion on whether a change in concentration of an element is cause or consequence of ADHD is not within the scope of this article.

Keywords: ADHD; Cu; Fe; Mg; Se; Zn; elemental status.

Publication types

  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Attention Deficit Disorder with Hyperactivity* / metabolism
  • Copper* / metabolism
  • Copper* / therapeutic use
  • Humans
  • Iron* / metabolism
  • Iron* / therapeutic use
  • Magnesium* / metabolism
  • Magnesium* / therapeutic use
  • Selenium* / metabolism
  • Selenium* / therapeutic use
  • Zinc* / metabolism
  • Zinc* / therapeutic use

Substances

  • Copper
  • Iron
  • Selenium
  • Magnesium
  • Zinc